Table 4.
AD (n=3,005) | VaD (n=1,011) | FTD (n=134) | LBD (n=244) | PPS (n=171) | DMA (n=159) | DNS (n=294) | DOD (n=138) | |
---|---|---|---|---|---|---|---|---|
Overall | 79.0 (76.1 to 81.2) | 74.4 (64.3 to 77.3) | 75.4 (69.0 to 80.5) | 78.6 (75.9 to 82.2) | 70.0 (66.2 to 74.7) | 65.6 (62.7 to 73.9) | 71.4 (64.4 to 80.3) | 69.2 (65.7 to 70.9) |
Gender | ||||||||
Male | 75.6 (64.7 to 78.9) | 74.5 (64.3 to 77.0) | 75.5 (69.0 to 81.1) | 80.6 (75.9 to 83.6) | 66.3 (66.2 to 75.3) | 66.0 (65.9 to 77.4) | 64.4 (64.4 to 76.8) | 69.6 (64.3 to 73.0) |
Female | 81.6 (78.1 to 83.8) | 73.3 (64.4 to 82.2) | 74.6 (69.7 to 80.8) | 77.1 (74.3 to 81.7) | 70.0 (67.3 to 82.4) | 62.7 (62.7 to 74.0) | 81.7 (71.4 to 86.1) | 68.8 (65.6 to 70.9) |
Age groups | ||||||||
60–69 | NA (74.7 to NA) | 73.1 (64.3 to NA) | 73.7 (69.0 to NA) | NA (NA to NA) | 70.0 (66.2 to NA) | 65.6 (62.7 to 71.4) | 71.7 (64.4 to NA) | 69.2 (65.6 to 70.9) |
70–79 | 82.5 (81.7 to 83.0) | 78.4 (76.4 to 80.5) | 80.8 (76.5 to 82.4) | 78.6 (75.9 to 81.6) | 78.7 (74.5 to 82.2) | 77.5 (73.6 to 80.3) | 79.2 (71.4 to 83.3) | 76.3 (71.7 to 80.9) |
80–89 | 87.4 (86.7 to 87.9) | 85.4 (84.5 to 86.5) | 86.0 (81.0 to 88.3) | 86.0 (84.8 to 87.1) | 80.2 (80.2 to 83.2) | 84.7 (80.9 to 87.8) | 86.5 (84.4 to 88.0) | 85.2 (81.3 to 88.3) |
90+ | 93.3 (92.3 to 93.9) | 92.6 (90.4 to 94.2) | NA (NA to NA) | 92.7 (91.4 to 94.1) | NA (91.1 to NA) | 90.9 (NA to NA) | 94.8 (92.5 to 95.6) | NA (NA to NA) |
CDR | ||||||||
Mild | 81.2 (77.8 to 83.0) | 75.9 (64.3 to 81.0) | 76.1 (69.7 to 81.1) | 79.1 (75.9 to 83.6) | 70.0 (66.2 to 78.3) | 65.6 (NA to NA) | 66.5 (64.4 to 84.6) | 70.1 (65.6 to 74.6) |
Moderate | 76.4 (69.9 to 79.2) | 75.4 (69.9 to 78.2) | 81.1 (74.6 to 86.9) | 70.0 (75,1 to 83.8) | 66.3 (66.3 to 74.3) | 62.7 (NA to NA) | 72.1 (71.4 to 76.7) | 68.3 (66.2 to 70.9) |
Severe | 74.8 (72.4 to 76.5) | 76.6 (74.7 to 78.8) | 70.3 (69.0 to NA) | 77.1 (74.3 to 82.2) | 66.1 (NA to NA) | 73.9 (NA to NA) | 77.7 (77.7 to 83.6) | 64.3 (NA to NA) |
Abbreviations: AD, Alzheimer’s disease; VaD, vascular dementia; FTD, frontotemporal dementia; LBD; Lewy body dementia; PPS, Parkinson-plus syndromes; DMA, dementia due to multiple aetiologies; DNS, dementia not specified; DOD, dementia in other diseases; NA, not available because of censored data on survival; CDR, clinical dementia rating; NA, not available because of censored data on survival; CDR, clinical dementia rating.